Acquisition and Market Reactions - Abbott Labs has entered into a definitive agreement to acquire Exact Sciences for $105 per share, representing a 22% premium over the closing price prior to the bid [1] - The acquisition will enhance Abbott's cancer diagnostics portfolio, particularly with the addition of the Cologuard home screening product line [1] - Exact Sciences shareholders have seen stock prices return to levels not seen since 2021 following the acquisition announcement [1] PACS Group Financial Performance - PACS Group experienced a 56% increase in stock price after reporting third-quarter revenue of $1.34 billion, a 31% year-over-year increase [2] - The company reported net income of $52.3 million, more than tripling its earnings from the previous year [2] - PACS has completed its audit committee investigation and restatement of past financial results, regaining compliance with SEC filing obligations [2] Stock Market Trends - Overall stock markets closed lower on Thursday, with the Nasdaq Composite dropping over 2% despite initial excitement from Nvidia's quarterly results [4][5] - Investors expressed concerns about the sustainability of the AI-led rally in the stock markets [4] Top Stock Losers - Bath & Body Works saw a 25% decline in stock price after reporting a 1% decrease in quarterly sales to $1.59 billion and a drop in earnings per share from $0.49 to $0.37 [6] - The company anticipates a high single-digit percentage decline in net sales for the holiday quarter and a potential 20% drop in earnings per share compared to the previous year's fourth quarter [6] - SanDisk's stock fell 20% despite a price target increase from Bank of America, as investors cooled on AI-related stocks [7]
Biggest Stock Movers Today, Nov. 20: PACS, BBWI, & More